FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2275985167> ?p ?o ?g. }

• W2275985167 endingPage "351" @default.
• W2275985167 startingPage "346" @default.
• W2275985167 abstract "Both antiresorptive and anabolic osteoporosis medications increase bone mineral density (BMD), but no single agent can restore normal bone strength in most osteoporotic patients. Moreover, the magnitude and consistency of the patient response to each individual agent vary depending on the anatomic site. In the DATA study, we reported that in postmenopausal osteoporotic women, 2 years of combined denosumab and teriparatide increase mean BMD at the hip and spine more than either drug alone. In the current analysis, we wished to determine if the individual rates of BMD response were also greater among women treated with both drugs. In DATA, 94 postmenopausal osteoporotic women (ages 51–91) were randomized to receive teriparatide (20 mcg subcutaneously daily), denosumab (60 mg subcutaneously every 6 mo), or both medications for 24 mo. The BMD of the total hip (TH), femoral neck (FN), and lumbar spine (LS) were assessed by dual-energy X-ray absorptiometry. The 82 subjects who completed all 2-yr treatments were analyzed. Responders were defined as experiencing BMD increases of >3%. An “excellent response” was defined as an increase of >6%. Over 24 mo, TH BMD increased by >3% in 36%, 53%, and 92% of women in the teriparatide, denosumab, and combination groups, respectively, and by >6% in 11%, 17%, and 50% in the teriparatide, denosumab, and combination groups, respectively (p < 0.01 for all comparisons vs combination). FN response rates were similar to TH. In the LS, BMD increased by >3% in 85%, 93%, and 100% of women in the teriparatide, denosumab, and combination groups, respectively (p = nonsignificant for all comparisons) and by >6% in 63%, 78%, and 100% of women in the teriparatide, denosumab, and combination groups, respectively (combination vs teriparatide, p = 0.001; combination vs denosumab, p = 0.016). In summary, more women treated with 24 mo of combined denosumab and teriparatide achieved a significant response at the TH and FN than those treated with either drug alone. All women treated with both agents together experienced an excellent response at the LS. These results support the continued investigation of combined denosumab and teriparatide therapy in postmenopausal osteoporotic women utilizing clinical endpoints such as fracture reduction." @default.
• W2275985167 created "2016-06-24" @default.
• W2275985167 creator A5010939572 @default.
• W2275985167 creator A5024994311 @default.
• W2275985167 creator A5039833315 @default.
• W2275985167 creator A5044388583 @default.
• W2275985167 creator A5064051504 @default.
• W2275985167 creator A5089621353 @default.
• W2275985167 date "2016-07-01" @default.
• W2275985167 modified "2023-10-14" @default.
• W2275985167 title "Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial" @default.
• W2275985167 cites W1979387767 @default.
• W2275985167 cites W1982069058 @default.
• W2275985167 cites W1989880575 @default.
• W2275985167 cites W2001078361 @default.
• W2275985167 cites W2014429962 @default.
• W2275985167 cites W2032093049 @default.
• W2275985167 cites W2032283776 @default.
• W2275985167 cites W2041578222 @default.
• W2275985167 cites W2057096224 @default.
• W2275985167 cites W2059670446 @default.
• W2275985167 cites W2061517003 @default.
• W2275985167 cites W2072952498 @default.
• W2275985167 cites W2073076949 @default.
• W2275985167 cites W2080881316 @default.
• W2275985167 cites W2090820041 @default.
• W2275985167 cites W2102177673 @default.
• W2275985167 cites W2103502150 @default.
• W2275985167 cites W2104372323 @default.
• W2275985167 cites W2113162921 @default.
• W2275985167 cites W2124476376 @default.
• W2275985167 cites W2160005424 @default.
• W2275985167 cites W2167706350 @default.
• W2275985167 cites W2171709369 @default.
• W2275985167 cites W2335178464 @default.
• W2275985167 doi "https://doi.org/10.1016/j.jocd.2016.01.004" @default.
• W2275985167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26900146" @default.
• W2275985167 hasPublicationYear "2016" @default.
• W2275985167 type Work @default.
• W2275985167 sameAs 2275985167 @default.
• W2275985167 citedByCount "26" @default.
• W2275985167 countsByYear W22759851672017 @default.
• W2275985167 countsByYear W22759851672018 @default.
• W2275985167 countsByYear W22759851672019 @default.
• W2275985167 countsByYear W22759851672020 @default.
• W2275985167 countsByYear W22759851672021 @default.
• W2275985167 countsByYear W22759851672022 @default.
• W2275985167 countsByYear W22759851672023 @default.
• W2275985167 crossrefType "journal-article" @default.
• W2275985167 hasAuthorship W2275985167A5010939572 @default.
• W2275985167 hasAuthorship W2275985167A5024994311 @default.
• W2275985167 hasAuthorship W2275985167A5039833315 @default.
• W2275985167 hasAuthorship W2275985167A5044388583 @default.
• W2275985167 hasAuthorship W2275985167A5064051504 @default.
• W2275985167 hasAuthorship W2275985167A5089621353 @default.
• W2275985167 hasConcept C126322002 @default.
• W2275985167 hasConcept C126894567 @default.
• W2275985167 hasConcept C168563851 @default.
• W2275985167 hasConcept C2775854910 @default.
• W2275985167 hasConcept C2776286101 @default.
• W2275985167 hasConcept C2776541429 @default.
• W2275985167 hasConcept C2776886416 @default.
• W2275985167 hasConcept C2777308945 @default.
• W2275985167 hasConcept C2779329777 @default.
• W2275985167 hasConcept C3018603563 @default.
• W2275985167 hasConcept C71924100 @default.
• W2275985167 hasConceptScore W2275985167C126322002 @default.
• W2275985167 hasConceptScore W2275985167C126894567 @default.
• W2275985167 hasConceptScore W2275985167C168563851 @default.
• W2275985167 hasConceptScore W2275985167C2775854910 @default.
• W2275985167 hasConceptScore W2275985167C2776286101 @default.
• W2275985167 hasConceptScore W2275985167C2776541429 @default.
• W2275985167 hasConceptScore W2275985167C2776886416 @default.
• W2275985167 hasConceptScore W2275985167C2777308945 @default.
• W2275985167 hasConceptScore W2275985167C2779329777 @default.
• W2275985167 hasConceptScore W2275985167C3018603563 @default.
• W2275985167 hasConceptScore W2275985167C71924100 @default.
• W2275985167 hasIssue "3" @default.
• W2275985167 hasLocation W22759851671 @default.
• W2275985167 hasLocation W22759851672 @default.
• W2275985167 hasOpenAccess W2275985167 @default.
• W2275985167 hasPrimaryLocation W22759851671 @default.
• W2275985167 hasRelatedWork W112985544 @default.
• W2275985167 hasRelatedWork W2083011022 @default.
• W2275985167 hasRelatedWork W2147302103 @default.
• W2275985167 hasRelatedWork W2335858853 @default.
• W2275985167 hasRelatedWork W2792750720 @default.
• W2275985167 hasRelatedWork W2795797384 @default.
• W2275985167 hasRelatedWork W3118667905 @default.
• W2275985167 hasRelatedWork W4376453587 @default.
• W2275985167 hasRelatedWork W2186476187 @default.
• W2275985167 hasRelatedWork W4235699389 @default.
• W2275985167 hasVolume "19" @default.
• W2275985167 isParatext "false" @default.
• W2275985167 isRetracted "false" @default.
• W2275985167 magId "2275985167" @default.
• W2275985167 workType "article" @default.